The Caspase-1 Digestome Identifies the Glycolysis Pathway As a Target During Infection and Septic Shock
Overview
Affiliations
Caspase-1 is an essential effector of inflammation, pyroptosis, and septic shock. Few caspase-1 substrates have been identified to date, and these substrates do not account for its wide range of actions. To understand the function of caspase-1, we initiated the systematic identification of its cellular substrates. Using the diagonal gel proteomic approach, we identified 41 proteins that are directly cleaved by caspase-1. Among these were chaperones, cytoskeletal and translation machinery proteins, and proteins involved in immunity. A series of unexpected proteins along the glycolysis pathway were also identified, including aldolase, triose-phosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, alpha-enolase, and pyruvate kinase. With the exception of the latter, the identified glycolysis enzymes were specifically cleaved in vitro by recombinant caspase-1, but not caspase-3. The enzymatic activity of wild-type glyceraldehyde-3-phosphate dehydrogenase, but not a non-cleavable mutant, was dampened by caspase-1 processing. In vivo, stimuli that fully activated caspase-1, including Salmonella typhimurium infection and septic shock, caused a pronounced processing of these proteins in the macrophage and diaphragm muscle, respectively. Notably, these stimuli inhibited glycolysis in wild-type cells compared with caspase-1-deficient cells. The systematic characterization of caspase-1 substrates identifies the glycolysis pathway as a caspase-1 target and provides new insights into its function during pyroptosis and septic shock.
An activation-based high throughput screen identifies caspase-10 inhibitors.
Castellon J, Yuen C, Han B, Andrews K, Ofori S, Julio A RSC Chem Biol. 2025; .
PMID: 40013156 PMC: 11854450. DOI: 10.1039/d5cb00017c.
He S, Ye J, Wang Y, Xie L, Liu S, Chen Q Heliyon. 2025; 11(3):e42201.
PMID: 39995931 PMC: 11848092. DOI: 10.1016/j.heliyon.2025.e42201.
Parkinson's disease models and death signaling: what do we know until now?.
Pedrao L, Medeiros P, Leandro E, Falquetto B Front Neuroanat. 2024; 18:1419108.
PMID: 39533977 PMC: 11555652. DOI: 10.3389/fnana.2024.1419108.
Domiciano T, Lee Y, Carvalho T, Wakita D, Martinon D, Jena P Clin Exp Immunol. 2024; 218(3):314-328.
PMID: 39250707 PMC: 11557146. DOI: 10.1093/cei/uxae080.
Mohamed S, Elsayed G, El Shaffai A, Yahya S, Mettwally W BMC Complement Med Ther. 2024; 24(1):244.
PMID: 38915036 PMC: 11194981. DOI: 10.1186/s12906-024-04512-3.